$28.13
-0.67 (-2.33%)
Analyst Consensus
Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
-45.3% upside
Low Target
$11.81
Average Target
$15.40
High Target
$21.79
Current Price
$28.13
Current
$28.13
$28.13
Target
$15.40
$15.40
$11.81
$15.40 avg
$21.79
Scenario Analysis
Bear Case
$11.81
-58.0%
Low target
Base Case
$15.40
-45.3%
Avg target
Bull Case
$21.79
+-22.5%
High target
Risk/Reward
0.4x
Unfavorable
Price in Context
52-Week High
$41.73
-32.6% from high
52-Week Low
$15.93
+76.6% from low
Target vs 52W High
$15.40
-63.1% vs high
Next Earnings Report
Aug 11, 2026 · After Market Close
2d
until earnings
EPS Est: $0.12
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 36 | 81% | $369.21 | -37.8% |
| DHR | Strong Buy | 32 | 84% | $158.11 | -22.8% |
| A | Strong Buy | 29 | 79% | $64.69 | -55.7% |
| WAT | Hold | 30 | 53% | $189.60 | -53.4% |
| IQV | Strong Buy | 29 | 76% | $82.96 | -65.2% |
| ILMN | Buy | 28 | 61% | $169.36 | -9.9% |
| MTD | Hold | 20 | 50% | $170.43 | -88.1% |
| WST | Strong Buy | 22 | 91% | $136.24 | -61.5% |